Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    paediatrics

    Acute lymphoblastic leukaemia

    Also known as: ALL, Acute lymphocytic leukaemia, B-cell acute lymphoblastic leukaemia, T-cell acute lymphoblastic leukaemia

    Acute lymphoblastic leukaemia (ALL) is a malignancy of immature lymphoid cells necessitating prompt paediatric haematology-oncology assessment and protocol-based treatment. Marrow dysfunction and treatment can cause infection, anaemia, and bleeding. Chinese-medicine patterns describe supportive-care symptoms, but do not classify leukaemia or guide cancer treatment. Any consideration of acupuncture must be coordinated with the oncology team; herbal formulas are traditional references, not recommendations during treatment. The supplied acupuncture study describes paediatric service utilisation, not efficacy in ALL. The salvage-treatment trial predominantly involved adults, the dasatinib report concerns an adult with another leukaemia, and record [1] has no abstract. These records establish no ALL-specific acupuncture or herbal benefit.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere to oncology team advice regarding infection prevention, food safety, and vaccination schedules; complementary care must not alter that plan.
    • •Perform thermometry exactly as prescribed and ensure emergency oncology contact details are readily accessible.
    • •Maintain regular sleep cycles and encourage gentle activity or play that is clinically approved and commensurate with the patient's fatigue levels and current haematological parameters.
    • •Monitor and record nutritional intake, fluid balance, bowel function, and weight trends; report clinical deterioration to the medical team immediately and refrain from initiating unsupervised supplementation.

    Cautions & Contraindications

    See sources
    • •Defer elective needling during fever, suspected infection, clinically significant neutropenia, active bleeding or clinically significant thrombocytopenia until oncology clearance. Use current blood results and local paediatric oncology policy, not universal numerical cut-offs. Record [2] documents these treatment complications but does not supply acupuncture safety thresholds.[]
    • •Do not interpret paediatric acupuncture utilisation as proof of efficacy or safety in an immunocompromised child with ALL; individual oncology authorisation and paediatric procedural expertise are necessary. Record [4] is retrospective service-use research, not an ALL safety trial.[]
    • •Defer complementary procedures for unexplained respiratory deterioration during dasatinib treatment and arrange medical assessment. Decisions about withholding or changing dasatinib belong to the treating specialist; [3] is an adult CML case report.[]

    When to reassess or seek care again

    See sources

    Before each proposed session, review oncology clearance, current blood results under local policy, infection symptoms, bruising, skin integrity and treatment changes. If supportive care proceeds, review within 7 days using age-appropriate nausea and fatigue scores, vomiting episodes, intake, sleep and adverse events. Stop and seek oncology review for deterioration; discontinue an ineffective intervention after a short agreed trial rather than escalating treatment. Leukaemia response remains the oncology team's responsibility.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. The Lancet. Haematology · 2026
    2. The Lancet. Haematology · 2025
    3. Respirology case reports · 2026
    4. BMC pediatrics · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.